188 related articles for article (PubMed ID: 6380844)
1. Immunopathological correlation between mesangial C3d-deposition and C3d-fixing circulating immune complexes in lupus nephritis.
Muso E; Sekita K; Doi T; Kuwahara T; Yoshida H; Tamura T; Kawai C; Hamashima Y
Clin Immunol Immunopathol; 1984 Sep; 32(3):351-8. PubMed ID: 6380844
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological study of patients with mesangial isolated C3d deposition in various glomerular diseases.
Doi T; Kanatsu K; Suehiro F; Nagai H; Yoshida H; Hamashima Y
Nephron; 1987; 46(2):188-93. PubMed ID: 3496550
[TBL] [Abstract][Full Text] [Related]
4. Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients.
Muso E; Yashiro M; Ito Y; Yoshida H; Sasayama S
Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):345-54. PubMed ID: 8022107
[TBL] [Abstract][Full Text] [Related]
5. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
6. Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis.
Schulze M; Pruchno CJ; Burns M; Baker PJ; Johnson RJ; Couser WG
Am J Pathol; 1993 Jan; 142(1):179-87. PubMed ID: 7678717
[TBL] [Abstract][Full Text] [Related]
7. Significance of glomerular deposition of C3c and C3d in IgA nephropathy.
Nakagawa H; Suzuki S; Haneda M; Gejyo F; Kikkawa R
Am J Nephrol; 2000; 20(2):122-8. PubMed ID: 10773612
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of C3d deposits in membranous nephropathy.
Doi T; Kanatsu K; Nagai H; Suehiro F; Kuwahara T; Hamashima Y
Nephron; 1984; 37(4):232-5. PubMed ID: 6379483
[TBL] [Abstract][Full Text] [Related]
9. IGA mesangial glomerulonephritis; significance and pathogenesis of segmental-focal glomerular lesions.
Syré G
Virchows Arch A Pathol Anat Histopathol; 1983; 402(1):11-24. PubMed ID: 6419453
[TBL] [Abstract][Full Text] [Related]
10. Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis.
Roberts JL; Wyatt RJ; Schwartz MM; Lewis EJ
Clin Immunol Immunopathol; 1983 Nov; 29(2):223-41. PubMed ID: 6605223
[TBL] [Abstract][Full Text] [Related]
11. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes of IgG, IgA, and IgM classes in various glomerular diseases.
Doi T; Kanatsu K; Sekita K; Yoshida H; Nagai H; Hamashima Y
Nephron; 1982; 32(4):335-41. PubMed ID: 6762505
[TBL] [Abstract][Full Text] [Related]
13. Primary glomerulonephritis with predominant mesangial immunoglobulin G deposits--a distinct entity?
Sato M; Kojima H; Nabeshima K; Nakajima Y; Koshikawa S
Nephron; 1993; 64(1):122-8. PubMed ID: 8502317
[TBL] [Abstract][Full Text] [Related]
14. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis.
Hisano S; Matsushita M; Fujita T; Endo Y; Takebayashi S
Am J Kidney Dis; 2001 Nov; 38(5):1082-8. PubMed ID: 11684563
[TBL] [Abstract][Full Text] [Related]
15. Composition of nephritic factor-generated glomerular deposits in membranoproliferative glomerulonephritis type 2.
West CD; Witte DP; McAdams AJ
Am J Kidney Dis; 2001 Jun; 37(6):1120-30. PubMed ID: 11382679
[TBL] [Abstract][Full Text] [Related]
16. Effect of enalapril therapy on glomerular accumulation of immune complexes and mesangial matrix in experimental glomerulonephritis in the nonhuman primate.
Hebert LA; Birmingham DJ; Mahan JD; Cosio FG; Dillon JJ; Sedmak DD; Shen XP; McAllister C
Am J Kidney Dis; 1997 Aug; 30(2):243-52. PubMed ID: 9261036
[TBL] [Abstract][Full Text] [Related]
17. Electron microscopy study of genesis and dynamics of immunodeposition in IgMk-IgG cryoglobulin-induced glomerulonephritis in mice.
Fornasieri A; Tazzari S; Li M; Armelloni S; Tarelli LT; Sessa A; D'Amico G
Am J Kidney Dis; 1998 Mar; 31(3):435-42. PubMed ID: 9506680
[TBL] [Abstract][Full Text] [Related]
18. Immune complex deposits in systemic lupus erythematosus kidney without histological or functional alterations.
Cruchaud A; Chenais F; Fournié GJ; Humair L; Lambert PH; Mulli JC; Chatelanat F
Eur J Clin Invest; 1975 Jun; 5(3):297-309. PubMed ID: 1149788
[TBL] [Abstract][Full Text] [Related]
19. ANCA-associated crescentic glomerulonephritis with immune complex deposits.
Sumida K; Ubara Y; Nomura K; Hoshino J; Suwabe T; Hiramatsu R; Hasegawa E; Hayami N; Yamanouchi M; Sawa N; Takemoto F; Takaichi K; Ohashi K
Clin Nephrol; 2012 Jun; 77(6):454-60. PubMed ID: 22595387
[TBL] [Abstract][Full Text] [Related]
20. Tubular basement membrane immune complex deposition is associated with activity and progression of lupus nephritis: a large multicenter Chinese study.
Wang H; Xu J; Zhang X; Ren YL; Cheng M; Guo ZL; Zhang JC; Cheng H; Xing GL; Wang SX; Yu F; Zhao MH
Lupus; 2018 Apr; 27(4):545-555. PubMed ID: 28954590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
